BackKiniksa Pharmaceuticals International Plc. Overview
Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A

Kiniksa Pharmaceuticals International Plc. Return on Equity

Kiniksa Pharmaceuticals International Plc. (KNSA) has a ROE of 12.06%, below the Healthcare sector average of 29.39%.

Get informed when a big investor buys or sells

+ Follow

ROE

12.06%

Return on Equity

12.06%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

Average ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Kiniksa Pharmaceuticals International Plc. (KNSA) FAQ

As of the most recent data, KNSA shows a ROE of 12.06%. That is below the Healthcare sector average of 29.39%. Scroll down for historical charts and peer comparison views.

The Healthcare sector average ROE is about 29.39%. Kiniksa Pharmaceuticals International Plc. is at 12.06%, which is lower that average. That is roughly 59.0% below the sector mean. Use the comparison chart on this page to see how KNSA stacks up against individual peers as well.

Check the historical chart to see whether KNSA's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Kiniksa Pharmaceuticals International Plc. with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has Kiniksa Pharmaceuticals International Plc.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 12.06%) with ownership activity and broader fundamentals.

The Healthcare average ROE is about 29.39%, while KNSA is at 12.06%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.